Immuron Ltd Files April 2024 6-K Report

Ticker: IMRN · Form: 6-K · Filed: Apr 15, 2024 · CIK: 1660046

Immuron LTD 6-K Filing Summary
FieldDetail
CompanyImmuron LTD (IMRN)
Form Type6-K
Filed DateApr 15, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: foreign-private-issuer, sec-filing, routine-report

Related Tickers: IMRN

TL;DR

Immuron Ltd (IMRN) filed its April 6-K, confirming foreign private issuer status and 20-F filing.

AI Summary

Immuron Limited filed a Form 6-K on April 15, 2024, reporting its activities for the month of April 2024. The filing indicates that the company is a foreign private issuer and will file annual reports under Form 20-F. The company's principal executive office is located in Carlton South, Victoria, Australia.

Why It Matters

This filing provides routine updates for investors and regulators regarding Immuron Limited's status as a foreign private issuer and its reporting obligations.

Risk Assessment

Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain significant new financial or operational information.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report information that Immuron Limited, as a foreign private issuer, has made or is required to make public in Australia or has filed or is required to file with the SEC.

Which annual report form does Immuron Limited file?

Immuron Limited files its annual reports under cover of Form 20-F.

Is Immuron Limited furnishing information under Rule 12g3-2(b)?

No, Immuron Limited is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934, as indicated by the 'No' checkbox.

Where is Immuron Limited's principal executive office located?

Immuron Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

What period does this Form 6-K cover?

This Form 6-K is for the month of April 2024, and it was filed as of April 15, 2024.

Filing Stats: 312 words · 1 min read · ~1 pages · Grade level 18.3 · Accepted 2024-04-15 08:00:18

Filing Documents

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on April 15, 2024 titled: - “Immuron to host Live Virtual Event” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron to host Live Virtual Event 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: April 15, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing